Update in community-acquired and nosocomial pneumonia 2009. (Q37728782)

22 August 2017

1 reference

title

Update in community-acquired and nosocomial pneumonia 2009. (English)

1 reference

22 August 2017

0 references

2

1 reference

22 August 2017

Antoni Torres

1

1 reference

22 August 2017

language of work or name

English

0 references

publication date

1 April 2010

1 reference

American Journal of Respiratory and Critical Care Medicine

22 August 2017

published in

1 reference

22 August 2017

volume

181

1 reference

22 August 2017

issue

8

1 reference

22 August 2017

page(s)

782-787

1 reference

BTS guidelines for the management of community acquired pneumonia in adults: update 2009

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1164/RCCM.201001-0030UP

Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/RCCM.201001-0030UP

The measurement of time to first antibiotic dose for pneumonia in the emergency department: a white paper and position statement prepared for the American Academy of Emergency Medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/RCCM.201001-0030UP

Risk stratification of early admission to the intensive care unit of patients with no major criteria of severe community-acquired pneumonia: development of an international prediction rule

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/RCCM.201001-0030UP

Thrombocytopenia and thrombocytosis at time of hospitalization predict mortality in patients with community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/RCCM.201001-0030UP

Admission hypoglycaemia is associated with adverse outcome in community-acquired pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/RCCM.201001-0030UP

PIRO score for community-acquired pneumonia: a new prediction rule for assessment of severity in intensive care unit patients with community-acquired pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/RCCM.201001-0030UP

Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/RCCM.201001-0030UP

Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/RCCM.201001-0030UP

Stability in community-acquired pneumonia: one step forward with markers?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/RCCM.201001-0030UP

Severity of pneumococcal pneumonia associated with genomic bacterial load

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/RCCM.201001-0030UP

Incidence, characteristics and outcomes of patients with severe community acquired-MRSA pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/RCCM.201001-0030UP

Community-acquired pneumonia through Enterobacteriaceae and Pseudomonas aeruginosa: Diagnosis, incidence and predictors

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/RCCM.201001-0030UP

Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/RCCM.201001-0030UP

Healthcare-associated pneumonia is a heterogeneous disease, and all patients do not need the same broad-spectrum antibiotic therapy as complex nosocomial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/RCCM.201001-0030UP

Rhinovirus disrupts the barrier function of polarized airway epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/RCCM.201001-0030UP

Antiviral activity of Nrf2 in a murine model of respiratory syncytial virus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/RCCM.201001-0030UP

Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/RCCM.201001-0030UP

Critical care services and 2009 H1N1 influenza in Australia and New Zealand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/RCCM.201001-0030UP

Critically ill patients with 2009 influenza A(H1N1) infection in Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/RCCM.201001-0030UP

Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/RCCM.201001-0030UP

Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/RCCM.201001-0030UP

Effectiveness of treatments for severe sepsis: a prospective, multicenter, observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/RCCM.201001-0030UP

Improving outcomes in elderly patients with community-acquired pneumonia by adhering to national guidelines: Community-Acquired Pneumonia Organization International cohort study results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/RCCM.201001-0030UP

Impact of intravenous {beta}-lactam/macrolide versus {beta}-lactam monotherapy on mortality in hospitalized patients with community-acquired pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/RCCM.201001-0030UP

A clinical evaluation committee assessment of recombinant human tissue factor pathway inhibitor (tifacogin) in patients with severe community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/RCCM.201001-0030UP

Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/RCCM.201001-0030UP

Treatment with protein synthesis inhibitors improves outcomes of secondary bacterial pneumonia after influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/RCCM.201001-0030UP

Phosphodiesterase 2 inhibition diminished acute lung injury in murine pneumococcal pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/RCCM.201001-0030UP

Efficacy of corticosteroids in community-acquired pneumonia: a randomized double-blinded clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/RCCM.201001-0030UP

Budesonide and the risk of pneumonia: a meta-analysis of individual patient data

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/RCCM.201001-0030UP

New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/RCCM.201001-0030UP

Differences in immune response may explain lower survival among older men with pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/RCCM.201001-0030UP

The influence of macrophage migration inhibitory factor gene polymorphisms on outcome from community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/RCCM.201001-0030UP

Pathogenesis, treatment, and prevention of pneumococcal pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/RCCM.201001-0030UP

The paradox of ventilator-associated pneumonia prevention measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/RCCM.201001-0030UP

Non-pharmacological prevention of ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/RCCM.201001-0030UP

Defining, treating and preventing hospital acquired pneumonia: European perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/RCCM.201001-0030UP

Advances in the prevention and management of ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/RCCM.201001-0030UP

Preventing ventilator-associated pneumonia in adults: sowing seeds of change

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/RCCM.201001-0030UP

Impact of patient position on the incidence of ventilator-associated pneumonia: a meta-analysis of randomized controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/RCCM.201001-0030UP

Effectiveness of routine patient cleansing with chlorhexidine gluconate for infection prevention in the medical intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/RCCM.201001-0030UP

Ventilator-associated pneumonia and oral care: a successful quality improvement project

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/RCCM.201001-0030UP

Oral decontamination with chlorhexidine reduces the incidence of ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/RCCM.201001-0030UP

A randomized trial of dental brushing for preventing ventilator-associated pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/RCCM.201001-0030UP

Effect of frequency of ventilator circuit changes (3 vs 7 days) on the rate of ventilator-associated pneumonia in PICU.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/RCCM.201001-0030UP

Duodenal versus gastric feeding in medical intensive care unit patients: a prospective, randomized, clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/RCCM.201001-0030UP

Early tracheotomy in elderly patients results in less ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/RCCM.201001-0030UP

Implementing quality improvements in the intensive care unit: ventilator bundle as an example

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/RCCM.201001-0030UP

Efficacy of an expanded ventilator bundle for the reduction of ventilator-associated pneumonia in the medical intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/RCCM.201001-0030UP

Implementation of a real-time compliance dashboard to help reduce SICU ventilator-associated pneumonia with the ventilator bundle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/RCCM.201001-0030UP

Successful prevention of ventilator-associated pneumonia in an intensive care setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/RCCM.201001-0030UP

Bundles to prevent ventilator-associated pneumonia: how valuable are they?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/RCCM.201001-0030UP

A European care bundle for prevention of ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/RCCM.201001-0030UP

Non-invasive ventilation after extubation in hypercapnic patients with chronic respiratory disorders: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/RCCM.201001-0030UP

Cost-Effectiveness Analysis of a Silver-Coated Endotracheal Tube to Reduce the Incidence of Ventilator-Associated Pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/RCCM.201001-0030UP

Combination antibiotic therapy with macrolides improves survival in intubated patients with community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164/RCCM.201001-0030UP

10.1164/RCCM.201001-0030UP

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference